Back

Investigation of the effect of the angiotensin II type 2 receptor (AT2R) agonist C21 on plasma NT-proBNP, a diagnostic biomarker, in subjects hospitalised with COVID-19

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Cardiovascular aspects of COVID and long-COVID Biomarkers ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Mrs Elin Rosendahl

Solna (Sweden)

7 More presentations in this session

Presentation thumbnail
The role of cardiac troponin-I as a prognostic tool for mortality in patients hospitalized with COVID-19
Doctor J. Quintal (Setubal, PT)
Abstract Slides
Presentation thumbnail
Expression changes of circulating ACE2 regulating-microRNA profiles in patients with COVID-19 during hospitalisation
Mrs C. Eyileten (Warsaw, PL)
Abstract Slides
Presentation thumbnail
Long COVID-19 syndrome: association of cardiopulmonary impairment with a persistent platelet activation.
Associate Professor M. Camera (Milan, IT)
Abstract Slides
Presentation thumbnail
Dysregulation of cardiac endothelial lncRNA H19 in COVID19 patients induces endothelial dysfunction, which impairs cardiomyocyte function
Doctor R. Juni (Amsterdam, NL)
Abstract Slides
Presentation thumbnail
Thrombosis-related miR-16-5p predicts the disease severity in patients hospitalised for COVID-19
Professor M. Postula (Warsaw, PL)
Abstract Slides

Access the full session

Session thumbnail
Cardiovascular aspects of COVID and long-COVID

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Webinar
Biomarkers of clinical utility in cardiovascular disease
thumbnail
Congress Presentation
Biomarker research in Circulation
thumbnail
Congress Presentation
Advancements and challenges in cardiovascular risk stratification: an overview of cardiac biomarkers

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources